These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15857582)

  • 1. The altered DNA methylation pattern and its implications in liver cancer.
    De Zhu J
    Cell Res; 2005 Apr; 15(4):272-80. PubMed ID: 15857582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation and hepatocellular carcinoma.
    Zhu J
    J Hepatobiliary Pancreat Surg; 2006; 13(4):265-73. PubMed ID: 16858536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.
    Zhao W; Liu H; Liu W; Wu Y; Chen W; Jiang B; Zhou Y; Xue R; Luo C; Wang L; Jiang JD; Liu J
    Int J Oncol; 2006 May; 28(5):1081-8. PubMed ID: 16596223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of genetic and epigenetic alterations in hepatocarcinogenesis.
    Herath NI; Leggett BA; MacDonald GA
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):15-21. PubMed ID: 16706806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
    Gao W; Kondo Y; Shen L; Shimizu Y; Sano T; Yamao K; Natsume A; Goto Y; Ito M; Murakami H; Osada H; Zhang J; Issa JP; Sekido Y
    Carcinogenesis; 2008 Oct; 29(10):1901-10. PubMed ID: 18632756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics of hepatocellular carcinoma: a new horizon.
    Liu WR; Shi YH; Peng YF; Fan J
    Chin Med J (Engl); 2012 Jul; 125(13):2349-60. PubMed ID: 22882861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
    Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
    Hsu LS; Lee HC; Chau GY; Yin PH; Chi CW; Lui WY
    Oncol Rep; 2006 Feb; 15(2):507-11. PubMed ID: 16391877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative and integrative functional genomics of HCC.
    Lee JS; Thorgeirsson SS
    Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling.
    Lehmann U; Berg-Ribbe I; Wingen LU; Brakensiek K; Becker T; Klempnauer J; Schlegelberger B; Kreipe H; Flemming P
    Clin Cancer Res; 2005 May; 11(10):3654-60. PubMed ID: 15897561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic targets in cancer epidemiology.
    Dumitrescu RG
    Methods Mol Biol; 2009; 471():457-67. PubMed ID: 19109794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current progress in epigenetic research for hepatocarcinomagenesis.
    Huang J
    Sci China C Life Sci; 2009 Jan; 52(1):31-42. PubMed ID: 19152082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
    Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
    Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis.
    Lehmann U; Wingen LU; Brakensiek K; Wedemeyer H; Becker T; Heim A; Metzig K; Hasemeier B; Kreipe H; Flemming P
    Hum Mol Genet; 2007 Jun; 16(11):1335-42. PubMed ID: 17412760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations.
    Rivenbark AG; Coleman WB
    Clin Cancer Res; 2007 Apr; 13(8):2309-12. PubMed ID: 17438087
    [No Abstract]   [Full Text] [Related]  

  • 20. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
    Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.